NCT05780853

Brief Summary

The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool. The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All participants will complete the tablet game-based assessment which aims to assess a range of neuropsychological functions including attention, memory, language, motor, executive functions and social-emotional skills. Parents/carers of participants will also complete a demographic questionnaire and the Adaptive Behaviour System - Third Edition (ABAS-3), which is a questionnaire that assesses a child's development. Some participants will be re-tested on the tablet game-based assessment approximately 2 weeks after the first tablet game-based assessment to ensure the game's validity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
590

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2023Jun 2026

Study Start

First participant enrolled

January 30, 2023

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 23, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

July 25, 2024

Status Verified

July 1, 2024

Enrollment Period

3.4 years

First QC Date

February 10, 2023

Last Update Submit

July 24, 2024

Conditions

Keywords

Diagnostic testNeurodevelopmentMedical technology

Outcome Measures

Primary Outcomes (4)

  • Diagnostic accuracy of the tablet game-based assessment

    Sensitivity and specificity of the tablet game-based assessment to accurately differentiate children's neurodevelopmental status.

    16 months

  • Construct validity of the tablet game-based assessment

    Using exploratory factor analysis to explore the construct validity of the tablet game-based assessment.

    16 months

  • Internal consistency of the tablet game-based assessment

    Cronbach's alpha and omega statistic to assess internal consistency/reliability of the tool, which assesses the extent to which all the items in the game-based assessment measure the same concept or construct.

    16 months

  • Known-group and predictive validity of the tablet game-based assessment

    Known-group and predictive validity will both be assessed through multiple logistic regression.

    16 months

Secondary Outcomes (4)

  • Preliminary normative data for performance on the tablet game-based assessment tool

    16 months

  • Acceptability of the tablet game-based assessment tool and device

    16 months

  • Re-test reliability of the tablet game-based assessment tool

    16 months

  • Safety of the tablet game-based assessment tool and device

    16 months

Other Outcomes (2)

  • Participant demographics

    16 months

  • Scores on the Adaptive Behavior Assessment System, Third Edition (ABAS-3)

    16 months

Study Arms (2)

Typically Developing Children (Control Group)

Typically developing children with no known neurodevelopmental disorder, medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.

Diagnostic Test: Tablet Game-based Assessment - YARN assessment serviceDiagnostic Test: Adaptive Behavior Assessment System, Third Edition (ABAS-3)Other: Demographic questionnaire

Children with a Diagnosed Neurodevelopmental Disorder (Clinical Group)

Children with a diagnosed neurodevelopmental disorder including: Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. Children must also have no known medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.

Diagnostic Test: Tablet Game-based Assessment - YARN assessment serviceDiagnostic Test: Adaptive Behavior Assessment System, Third Edition (ABAS-3)Other: Demographic questionnaire

Interventions

Tablet game-based assessment to assess neurodevelopmental profile.

Children with a Diagnosed Neurodevelopmental Disorder (Clinical Group)Typically Developing Children (Control Group)

A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.

Children with a Diagnosed Neurodevelopmental Disorder (Clinical Group)Typically Developing Children (Control Group)

Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.

Children with a Diagnosed Neurodevelopmental Disorder (Clinical Group)Typically Developing Children (Control Group)

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children will be recruited into the study from nurseries, preschools, infant and primary schools across the United Kingdom. The study will also be shared across local libraries, playgroups, online parenting forums and groups, and parent-specific publications to make parents aware of the study.

You may qualify if:

  • to 8 year old 'typically' developing children with no known neurodevelopmental disorder.
  • to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
  • All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.

You may not qualify if:

  • Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brightlobe Limited

London, United Kingdom

RECRUITING

MeSH Terms

Conditions

Neurodevelopmental DisordersAutism Spectrum DisorderAttention Deficit Disorder with HyperactivityDyslexiaSpecific Learning Disorder

Condition Hierarchy (Ancestors)

Mental DisordersChild Development Disorders, PervasiveAttention Deficit and Disruptive Behavior DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesLearning DisabilitiesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jane Iles, PhD DClinPsy

    Brightlobe Limited

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

March 23, 2023

Study Start

January 30, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

July 25, 2024

Record last verified: 2024-07

Locations